138 related articles for article (PubMed ID: 34044270)
1. Visceral obesity is associated with lower stage colon tumors in males without survival advantage.
Silva A; Gomes F; Pereira SS; Monteiro MP; Araújo A; Faria G
Surg Oncol; 2021 Jun; 37():101606. PubMed ID: 34044270
[TBL] [Abstract][Full Text] [Related]
2. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
3. Visceral Obesity Predicts Fewer Lymph Node Metastases and Better Overall Survival in Colon Cancer.
Park SW; Lee HL; Doo EY; Lee KN; Jun DW; Lee OY; Han DS; Yoon BC; Choi HS; Lee KH
J Gastrointest Surg; 2015 Aug; 19(8):1513-21. PubMed ID: 25941028
[TBL] [Abstract][Full Text] [Related]
4. Determinants of lymph node count and positivity in patients undergoing surgery for colon cancer.
Dolan RD; McSorley ST; Horgan PG; McMillan DC
Medicine (Baltimore); 2018 Mar; 97(13):e0185. PubMed ID: 29595652
[TBL] [Abstract][Full Text] [Related]
5. Impact of Increased Visceral Fat Measured by CT on Colon Adenocarcinoma Stage.
Mahamid A; Ashkenazi I; Shapira-Rootman M; Olsha O; Alfici R; Bekhor EY; Mouch IA; Zeina AR
J Gastrointest Cancer; 2017 Dec; 48(4):347-352. PubMed ID: 27826814
[TBL] [Abstract][Full Text] [Related]
6. Association of visceral obesity and early colorectal neoplasia.
Choe EK; Kim D; Kim HJ; Park KJ
World J Gastroenterol; 2013 Dec; 19(45):8349-56. PubMed ID: 24363527
[TBL] [Abstract][Full Text] [Related]
7. Relationship between inflammatory markers and visceral obesity in obese and overweight Korean adults: An observational study.
Yu JY; Choi WJ; Lee HS; Lee JW
Medicine (Baltimore); 2019 Mar; 98(9):e14740. PubMed ID: 30817629
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma.
Zhang Y; Jiang C; Li J; Sun J; Qu X
Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119
[TBL] [Abstract][Full Text] [Related]
9. Quantitative measures of visceral adiposity and body mass index in predicting rectal cancer outcomes after neoadjuvant chemoradiation.
Clark W; Siegel EM; Chen YA; Zhao X; Parsons CM; Hernandez JM; Weber J; Thareja S; Choi J; Shibata D
J Am Coll Surg; 2013 Jun; 216(6):1070-81. PubMed ID: 23523147
[TBL] [Abstract][Full Text] [Related]
10. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
11. Visceral obesity and colorectal cancer: are we missing the boat with BMI?
Rickles AS; Iannuzzi JC; Mironov O; Deeb AP; Sharma A; Fleming FJ; Monson JR
J Gastrointest Surg; 2013 Jan; 17(1):133-43; discussion p.143. PubMed ID: 23090279
[TBL] [Abstract][Full Text] [Related]
12. Preoperative prognostic nutritional index predicts risk of recurrence after curative resection for stage IIA colon cancer.
Maruyama T; Shimoda M; Hakoda H; Sako A; Ueda K; Suzuki S
Am J Surg; 2021 Jul; 222(1):179-185. PubMed ID: 33138968
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Lymph Node Metastasis in Colon Cancer via Platelet to Lymphocyte Ratio and Platelet Count.
Catal O; Ozer B; Sit M
J Coll Physicians Surg Pak; 2020 Mar; 30(3):250-253. PubMed ID: 32169130
[TBL] [Abstract][Full Text] [Related]
14. Impact of visceral obesity and sarcobesity on surgical outcomes and recovery after laparoscopic resection for colorectal cancer.
Pedrazzani C; Conti C; Zamboni GA; Chincarini M; Turri G; Valdegamberi A; Guglielmi A
Clin Nutr; 2020 Dec; 39(12):3763-3770. PubMed ID: 32336524
[TBL] [Abstract][Full Text] [Related]
15. Elevated visceral fat area is associated with adverse postoperative outcome of radical colectomy for colon adenocarcinoma patients.
Zhai TS; Kang Y; Ren WH; Liu Q; Liu C; Mao WZ
ANZ J Surg; 2019 Sep; 89(9):E368-E372. PubMed ID: 31206986
[TBL] [Abstract][Full Text] [Related]
16. Visceral obesity in predicting oncologic outcomes of localized renal cell carcinoma.
Park YH; Lee JK; Kim KM; Kook HR; Lee H; Kim KB; Lee S; Byun SS; Lee SE
J Urol; 2014 Oct; 192(4):1043-9. PubMed ID: 24704011
[TBL] [Abstract][Full Text] [Related]
17. Perirenal Fat Surface Area and Oncologic Outcome in Elective Colon Cancer Surgery.
Eckberg SE; Dahlberg MJA; der Hagopian OS; Farahnak P; Sandblom GK; Nordenvall CAM; Everhov ÅH
Dis Colon Rectum; 2021 Feb; 64(2):171-180. PubMed ID: 33315716
[TBL] [Abstract][Full Text] [Related]
18. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of neutrophil-lymphocyte ratio and level of C-reactive protein in a large cohort of pancreatic cancer patients: a retrospective study in a single institute in Japan.
Inoue D; Ozaka M; Matsuyama M; Yamada I; Takano K; Saiura A; Ishii H
Jpn J Clin Oncol; 2015 Jan; 45(1):61-6. PubMed ID: 25341546
[TBL] [Abstract][Full Text] [Related]
20. A prognostic model to predict survival in stage III colon cancer patients based on histological grade, preoperative carcinoembryonic antigen level and the neutrophil lymphocyte ratio.
Wuxiao ZJ; Zhou HY; Wang KF; Chen XQ; Hao XB; Lu YD; Xia ZJ
Asian Pac J Cancer Prev; 2015; 16(2):747-51. PubMed ID: 25684519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]